Excellent review of CLL Treatment : The New... - CLL Support
Excellent review of CLL Treatment
You need to be a member of this community to see this post.
Read more about...
4 Replies
You need to be a member of this community to see hidden responses.
Not what you're looking for?
You may also like...
OncLive 9 CLL Videos - Optimizing the Treatment of CLL With Novel Therapies and more Take-home messages from ASH 2021
The OncLive Chronic Lymphocytic Leukemia condition center page is a comprehensive resource for...
BTK inhibitors for the treatment of CLL - the current state of play of 'brutinibs'
In just a short time, in many places, BTK inhibitors (BTKi) have largely replaced...
New drug: MS-553 inhibitor for CLL/SLL who develop resistance to BTK inhibitors
MS-553 is a protein kinase C-beta (PKCß) inhibitor designed to be an alternative treatment option...
Clemastine (Tavegyl), an over-the-counter drug, found to be effective at inducing LMP and cell death
For what it may be worth, thougbt some of you might like to see this:
"Lysosomes in chronic...
Revolution of Chronic Lymphocytic Leukemia Therapy: the Chemo-Free Treatment Paradigm
February 2020
A long paper and too much information to be able to summarise in this post but a nice...
Related Posts
YABTKi or Yet Another BTK inhibitor - an A to Z list of Bruton's Tyrosine Kinase Inhibitors and Degraders following ibrutinib's success
ASH 2019 CLL highlights and 'hot' topics - Drs Nicole Lamanna & Florence Cymbalista- PI3K inhibitors (idelalisib,copanlisib, duvelisib, parsaclisib, umbralisib, zandelisib, ACP-319) in CLL: where do we go from here?
Resistance-Associated Mutations in CLL Patients Treated With Novel Agents- Leukemia-associated macrophages, their role in the CLL Tumor Micro-environment and how they affect progression and therapy response
